Business Insider

NanoString Announces Launch of Breast Cancer 360 Research Panel, Expanding the 360 Series of Cancer Panels for Translational Research and Signature Development

SEATTLE, April 10, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced ...
Business Wire

NanoString Launches the Most Comprehensive Spatial Proteomics Panel Ever Offered

SEATTLE--(BUSINESS WIRE)--NanoString Technologies (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, announced today the launch of the latest assay for ...
Business Wire

NanoString Customers Present First Data Using the Most Comprehensive Spatial Proteomics Panel Available

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, a leading provider of life sciences tools for discovery and translational research, announced today the line-up of researchers joining NanoString at ...
Nasdaq

NanoString Launches nCounter Stem Cell Characterization Panel to Advance the Development of Stem Cell Therapy

SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of the nCounter® ...
Business Insider

NanoString Announces Collaboration with National Cancer Institute to Improve Cancer Immunotherapy Biomarker DiscoveryNanoString’s PanCancer IO 360 panel will be used for ...

SEATTLE, June 04, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced a ...